12th August 2022
- 0 comments
VascVersa, an award winning, early-stage regenerative medicine spin out from Queen’s University in Belfast, has completed its second seed funding round, raising over £500,000. The investment was participated in by Co-Fund NI (managed by Clarendon Fund Managers), QUBIS, the commercialisation arm of Queen’s University Belfast, the Innovation Investment Fund and angel investors from the Halo & Business Angel Network (HBAN).
...In order to read the full story we need you to be registered with us, please click the links below to login or register.